Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 7Phase 1/2 5Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Breast Neoplasms 13Lymphoma, Large B-Cell, Diffuse 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasm, Residual 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Burkitt Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Leukemia 2Hodgkin Disease 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Rhabdomyosarcoma 1Recurrence 1Obesity 1Neoplasms, Plasma Cell 1Neoplasms 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1

Interventions

prednylidene 1pirarubicin 1etoposide phosphate 1Vincristine 1Prednisone 1Methotrexate 1Ifosfamide 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Immunoblastic Lymphadenopathy × Cyclophosphamide × Clear all
NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡